|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham SC, Kamangar F, Kim MP, Hammoud
S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA,
Lillemoe KD, et al: Survival after gastric adenocarcinoma
resection: Eighteen-year experience at a single institution. J
Gastrointest Surg. 9:718–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stewart B and Wild CP: World Cancer Report
2014. Health. 2017.
|
|
4
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Florea AM and Büsselberg D: Cisplatin as
an anti-tumor drug: Cellular mechanisms of activity, drug
resistance and induced side effects. Cancers (Basel). 3:1351–1371.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Q, Yang Z, Nie Y, Shi Y and Fan D:
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and
lab approaches. Cancer Lett. 347:159–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
James MI, Iwuji C, Irving G, Karmokar A,
Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR,
et al: Curcumin inhibits cancer stem cell phenotypes in ex vivo
models of colorectal liver metastases, and is clinically safe and
tolerable in combination with FOLFOX chemotherapy. Cancer Lett.
364:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He B, Wei W, Liu J, Xu Y and Zhao G:
Synergistic anticancer effect of curcumin and chemotherapy regimen
FP in human gastric cancer MGC-803 cells. Oncol Lett. 14:3387–3394.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tran KQ, Tin AS and Firestone GL:
Artemisinin triggers a G1 cell cycle arrest of human Ishikawa
endometrial cancer cells and inhibits Cyclin Dependent Kinase-4
promoter activity and expression by disrupting NF-kB
transcriptional signaling. Anticancer Drugs. 25:270–281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Novelle MG, Wahl D, Diéguez C, Bernier M
and de Cabo R: Resveratrol supplementation: Where are we now and
where should we go? Ageing Res Rev. 21:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: The in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du RH, Dai T, Cao WJ, Lu M, Ding JH and Hu
G: Kir6.2-containing ATP-sensitive K(+) channel is required for
cardioprotection of resveratrol in mice. Cardiovasc Diabetol.
13:352014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Inglés M, Gambini J, Miguel MG,
Bonet-Costa V, Abdelaziz KM, El Alami M, Viña J and Borrás C: PTEN
mediates the antioxidant effect of resveratrol at nutritionally
relevant concentrations. Biomed Res Int. 2014:5808522014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Labinskyy N, Csiszar A, Veress G, Stef G,
Pacher P, Oroszi G, Wu J and Ungvari Z: Vascular dysfunction in
aging: Potential effects of resveratrol, an anti-inflammatory
phytoestrogen. Curr Med Chem. 13:989–996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valenzano DR, Terzibasi E, Genade T,
Cattaneo A, Domenici L and Cellerino A: Resveratrol prolongs
lifespan and retards the onset of age-related markers in a
short-lived vertebrate. Curr Biol. 16:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou
Y, Zhu J and Mi M: Resveratrol inhibits breast cancer stem-like
cells and induces autophagy via suppressing Wnt/β-catenin signaling
pathway. PLoS One. 9:e1025352014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF
and Zhang J: Growth inhibition and apoptosis induction of
tanshinone II-A on human hepatocellular carcinoma cells. World J
Gastroenterol. 10:2024–2028. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arora S, Jain J, Rajwade J and Paknikar K:
Interactions of silver nanoparticles with primary mouse fibroblasts
and liver cells. Toxicol Appl Pharmacol. 236:310–318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Zhao G, Wang F, Gao F, Luo H, Wang
Y, Du Y, Chen X, Xue C, Dong Z and Song G: Upregulation of miR-513b
inhibits cell proliferation, migration, and promotes apoptosis by
targeting high mobility group-box 3 protein in gastric cancer.
Tumor Biol. 35:11081–11089. 2014. View Article : Google Scholar
|
|
21
|
Guo H, Xu YM, Ye ZQ, Yu JH and Hu XY:
Curcumin induces cell cycle arrest and apoptosis of prostate cancer
cells by regulating the expression of IkappaBalpha, c-Jun and
androgen receptor. Pharmazie. 68:431–434. 2013.PubMed/NCBI
|
|
22
|
Zhu P, Zhang J, Zhu J, Shi J, Zhu Q and
Gao Y: MiR-429 induces gastric carcinoma cell apoptosis through
Bcl-2. Cell Physiol Biochem. 37:1572–1580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding XZ and Adrian TE: Resveratrol
inhibits proliferation and induces apoptosis in human pancreatic
cancer cells. Pancreas. 25:e71–e76. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu XD, Yang JL, Zhang WL and Liu DX:
Resveratrol inhibits oral squamous cell carcinoma through induction
of apoptosis and G2/M phase cell cycle arrest. Tumour Biol.
37:2871–2877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Opipari AW Jr, Tan L, Boitano AE, Sorenson
DR, Aurora A and Liu JR: Resveratrol-induced autophagocytosis in
ovarian cancer cells. Cancer Res. 64:696–703. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L,
Bickers DR and Athar M: Resveratrol inhibits proliferation of human
epidermoid carcinoma A431 cells by modulating MEK1 and AP-1
signalling pathways. Exp Dermatol. 15:538–546. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Galluzzi L, Vitale I, Abrams JM, Alnemri
ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry
WS, Fulda S, et al: Molecular definitions of cell death
subroutines: Recommendations of the nomenclature committee on cell
death 2012. Cell Death Differ. 19:107–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(−/low/CD44+ breast cancer-initiating cells to
radiation. J Natl Cancer Inst. 98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: Apoptosomes or mitochondria? Genes to cells.
3:697–707. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Estrov Z, Thall PF, Talpaz M, Estey EH,
Kantarjian HM, Andreeff M, Harris D, Van Q, Walterscheid M and
Kornblau SM: Caspase 2 and caspase 3 protein levels as predictors
of survival in acute myelogenous leukemia. Blood. 92:3090–3097.
1998.PubMed/NCBI
|
|
32
|
Hopkins-Donaldson S, Bodmer JL, Bourloud
KB, Brognara CB, Tschopp J and Gross N: Loss of caspase-8
expression in highly malignant human neuroblastoma cells correlates
with resistance to tumor necrosis factor-related apoptosis-inducing
ligand-induced apoptosis. Cancer Res. 60:4315–4319. 2000.PubMed/NCBI
|
|
33
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gasparini C, Celeghini C, Monasta L and
Zauli G: NF-κB pathways in hematological malignancies. Cell Mol
Life Sc. 71:2083–2102. 2014. View Article : Google Scholar
|
|
35
|
Pacifico F and Leonardi A: NF-kappaB in
solid tumors. Biochem Pharmacol. 72:1142–1152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A Cytoplasmic NF-κB interacting
long noncoding RNA Blocks IκB Phosphorylation and suppresses breast
cancer metastasis. Cancer Cell. 27:370–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Catz SD and Johnson JL: Transcriptional
regulation of bcl-2 by nuclear factor kappa B and its significance
in prostate cancer. Oncogene. 20:7342–7351. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li F and Sethi G: Targeting transcription
factor NF-kappaB to overcome chemoresistance and radioresistance in
cancer therapy. Biochim Biophys Acta. 1805:167–180. 2010.PubMed/NCBI
|
|
40
|
Sun C, Hu Y, Liu X, Wu T, Wang Y, He W and
Wei W: Resveratrol downregulates the constitutional activation of
nuclear factor-kappaB in multiple myeloma cells, leading to
suppression of proliferation and invasion, arrest of cell cycle,
and induction of apoptosis. Cancer Genet Cytogenet. 165:9–19. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shimizu T, Nakazato T, Xian MJ, Sagawa M,
Ikeda Y and Kizaki M: Resveratrol induces apoptosis of human
malignant B cells by activation of caspase-3 and p38 MAP kinase
pathways. Biochem Pharmacol. 71:742–750. 2006. View Article : Google Scholar : PubMed/NCBI
|
